about
Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionPost-translational modifications as key regulators of TNF-induced necroptosisPrinciples of antibody-mediated TNF receptor activationIs there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programsCellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicityc-IAP1 and c-IAP2 redundancy differs between T and B cells.Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Intrinsic TNF/TNFR2 interactions fine-tune the CD8 T cell response to respiratory influenza virus infection in mice.Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling.Regulation of NF-κB by the CARD proteinsMolecular basis of NF-κB signalingTRAF4, at the Crossroad between Morphogenesis and Cancer.IAP proteins as targets for drug development in oncologyRegulation of Apoptosis by Inhibitors of Apoptosis (IAPs)Molecular cell death platforms and assemblies.Structural studies of NF-κB signaling.TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer.T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.NAIPs: building an innate immune barrier against bacterial pathogens. NAIPs function as sensors that initiate innate immunity by detection of bacterial proteins in the host cell cytosol.Zinc-rich inhibitor of apoptosis proteins (IAPs) as regulatory factors in the epithelium of normal and inflamed airways.The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy.Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.IAPs and Cell Death.Investigations of Pro- and Anti-Apoptotic Factors Affecting African Swine Fever Virus Replication and Pathogenesis.Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells.Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection.The Role of Ubiquitination in TWEAK-Stimulated Signaling.An apoptosis-independent role of SMAC in tumor suppressioncIAP1 regulates TNF-mediated cdc42 activation and filopodia formation.Inhibitors of apoptosis: clinical implications in cancer.Structural principles of tumor necrosis factor superfamily signaling.Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
P2860
Q24306110-8821528A-C8BF-4F0C-A4BA-77D9EF992C9FQ26744244-286ABE58-D75C-43B4-94C0-319D6E475C85Q26796270-F5065C16-E18A-49FE-AC74-7AEF34F0F2B2Q26996617-04DE4105-19EA-4AAB-A3E9-4A89BFA628B3Q28540934-A7A8EEA2-08AF-4D1C-9EB4-3C215FCEF136Q31120747-9A07F7E9-EAF5-4D73-8F3C-115EEC279B5FQ33632016-F36AD47C-B90C-4A21-B4F9-8E9E78A4A036Q34851737-BCA8D049-BFC6-4C6C-B3CD-16A1899CC471Q35049396-4671CEA4-D557-4D1B-A26D-4B0CCA36C26AQ35920998-3616BDFE-398F-47F4-B4C1-28C63B9ED870Q36918115-24E92D3F-E2C2-4502-AFF3-CB0FADB77575Q37132817-FD69ED5F-5E87-4BB4-A0F1-01077F4B2692Q37209606-51BDB761-8301-41E4-93E5-E03606ABD113Q37679203-57932AA6-206E-4CA9-BAC6-FD7BCAB9EA30Q37785354-4C8D57B4-8EA4-4B82-B245-D7A2A1457814Q37816940-D9DBEB5C-2C3A-40C1-BD2B-35882AC30246Q37948115-4DFE68BA-AE9C-4CA1-A9A5-4FE54A4F9346Q37948129-3FF4223A-BDC0-477D-9E67-9DF8357E5D8DQ38003578-A31B0979-01E5-4324-B075-793463AB62BBQ38086464-DD207034-78FC-4E28-8CB4-7538224AB1A5Q38129083-1892E186-A8E0-4247-9361-CEF27DCD0E49Q38239689-018B72AA-3597-47DF-9C8F-CCB74FD0D6C4Q38391583-76EFD28A-625B-4FBB-B1AF-2E7EBE7833D8Q38698632-1CFF07CB-7AAE-44E9-9E2E-D43059F12F62Q39138078-63025590-B612-4670-88E8-E5FCD2D569D6Q40041944-AFC3F429-EEC7-4AA8-A2C3-075955892841Q40349474-E7669E0C-70E3-41A8-9622-962F311F54DDQ41173599-1CA65F29-9AF5-46DF-9D2D-BB8B6D90379FQ41907326-5FE6364F-8940-467E-AD14-854B80C9AEB0Q41998116-F8B6D693-3844-4087-8384-1C4AF8DED8CDQ42810030-615EC357-677D-48FA-B88B-822715B079A7Q47607136-170ABD60-44D0-468B-8D1D-7B001238D74EQ48319204-B3FD36B4-69BD-4E85-8366-542C185C9956Q50420978-2F8DBC67-4F82-43F5-86D4-F15CF5B59A3B
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Asymmetric recruitment of cIAPs by TRAF2
@ast
Asymmetric recruitment of cIAPs by TRAF2
@en
Asymmetric recruitment of cIAPs by TRAF2
@en-gb
Asymmetric recruitment of cIAPs by TRAF2
@nl
type
label
Asymmetric recruitment of cIAPs by TRAF2
@ast
Asymmetric recruitment of cIAPs by TRAF2
@en
Asymmetric recruitment of cIAPs by TRAF2
@en-gb
Asymmetric recruitment of cIAPs by TRAF2
@nl
prefLabel
Asymmetric recruitment of cIAPs by TRAF2
@ast
Asymmetric recruitment of cIAPs by TRAF2
@en
Asymmetric recruitment of cIAPs by TRAF2
@en-gb
Asymmetric recruitment of cIAPs by TRAF2
@nl
P50
P921
P3181
P1476
Asymmetric recruitment of cIAPs by TRAF2
@en
P3181
P356
10.1016/J.JMB.2010.04.055
P407
P577
2010-07-02T00:00:00Z